Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma - Groupe Structure et Activité des Glycosaminoglycanes / Structure and Activity of Glycosaminoglycans Group (IBS-SAGAG) Accéder directement au contenu
Article Dans Une Revue Cellular Signalling Année : 2015

Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma

Résumé

Keywords: Syndecan-1 Malignant mesothelioma Transcription factor Mitogen-activated protein kinase (MAPK) Receptor tyrosine kinase Syndecan-1 is a proteoglycan that acts as co-receptor through its heparan sulfate (HS) chains and plays important roles in cancer. HS chains are highly variable in length and sulfation pattern. This variability is enhanced by the SULF1/2 enzymes, which remove 6-O-sulfates from HS. We used malignant mesothelioma, an aggressive tumor with poor prognosis, as a model and demonstrated that syndecan-1 over-expression down-regulates SULF1 and alters the HS biosynthetic machinery. Biochemical characterization revealed a 2.7-fold reduction in HS content upon syndecan-1 over-expression, but an overall increase in sulfation. Consistent with low SULF1 levels, trisulfated disaccharides increased 2.5-fold. ERK1/2 activity was enhanced 6-fold. Counteracting ERK activation , Akt, WNK1, and c-Jun were inhibited. The net effect of these changes manifested in G1 cell cycle arrest. Studies of pleural effusions showed that SULF1 levels are lower in pleural malignancies compared to benign conditions and inversely correlate with the amounts of syndecan-1, suggesting important roles for syndecan-1 and SULF1 in malignant mesothelioma.
Fichier principal
Vignette du fichier
Heidari-Hamedani et al., 2015 Cell signal.pdf (1.38 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01233139 , version 1 (03-07-2017)

Identifiants

Citer

Ghazal Heidari-Hamedani, Romain R Vivès, Amal Seffouh, Nikolaos A Afratis, Arie Oosterhof, et al.. Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma. Cellular Signalling, 2015, 27 (10), pp.2054-67. ⟨10.1016/j.cellsig.2015.07.017⟩. ⟨hal-01233139⟩
504 Consultations
135 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More